Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis-Reference-Cited by-同舟云学术

Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis

Published:2014-04 Issue:4 Volume:32 Page:771-783
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Ocaranza Maria Paz,Moya Jackeline,Barrientos Victor,Alzamora Rodrigo,Hevia Daniel,Morales Cristobal,Pinto Melissa,Escudero Nicolás,García Lorena,Novoa Ulises,Ayala Pedro,Díaz-Araya Guillermo,Godoy Ivan,Chiong Mario,Lavandero Sergio,Jalil Jorge E.,Michea Luis

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference47 articles.

1. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research.;Ferrario;J Renin Angiotensin Aldosterone Syst,2006

2. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.;Donoghue;Circ Res,2000

3. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.;Santos;Proc Natl Acad Sci U S A,2003

4. Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.;Erdos;J Mol Cell Cardiol,2002

5. Angiotensin-converting enzyme-2: a molecular and cellular perspective.;Warner;Cell Mol Life Sci,2004

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Induced Skin Fibrosis (RISF): Opportunity for Angiotensin II-Dependent Intervention;International Journal of Molecular Sciences;2024-07-29

2. Angiotensin-II type 2 receptor-mediated renoprotection is independent of receptor Mas in obese Zucker rats fed high-sodium diet;Frontiers in Pharmacology;2024-07-29

3. Renin–angiotensin system inhibitors positively impact on multiple aging regulatory pathways: Could they be used to protect against human aging?;Physiological Reports;2024-06

4. Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?;Frontiers in Pharmacology;2024-04-10

5. Classical and Alternative Pathways of the Renin–Angiotensin–Aldosterone System in Regulating Blood Pressure in Hypertension and Obese Adolescents;Biomedicines;2024-03-10